| LO FUNDS - ASIA HIGH CONVICTION (USD) N CAP | RVI ASIA EX-JAPÓN | 263,990925 | 30/10/2026 | 17,90% | 88,72% | ***** |
| MIROVA THEMATIC AI & ROBOTICS R/A (USD) | RVI TECNOLOGÍA | 295,524251 | 02/11/2026 | 17,90% | 64,33% | ** |
| BGF US FLEXIBLE EQUITY A2 USD | RVI USA | 88,801712 | 02/11/2026 | 17,89% | 75,94% | **** |
| CARMIGNAC INVESTISSEMENT A EUR Y DIS | RVI GLOBAL | 332,330000 | 02/11/2026 | 17,89% | 79,60% | ***** |
| CT (LUX) GLOBAL FOCUS IE EUR | RVI GLOBAL | 34,347000 | 02/11/2026 | 17,89% | 68,22% | ***** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 124,942891 | 02/11/2026 | 17,89% | 46,57% | ** |
| UBS (LUX) SECURITY EQUITY (CHF HEDGED) I-A1-ACC | RVI OTROS SECTORES | 1.989,644329 | 30/10/2026 | 17,89% | 66,88% | *** |
| BANKINTER EMERGENTES, FI C | RVI EMERGENTES | 156,160440 | 02/11/2026 | 17,88% | 64,45% | ** |
| BGF WORLD HEALTHSCIENCE A2 USD | RVI BIOTECNOLOGÍA | 75,249643 | 02/11/2026 | 17,88% | 31,99% | * |
| ERSTE STOCK EUROPE EMERGING HUF R01 KEST-EXEMPT CAP | RVI EMERGENTES EUROPA | 113,767791 | 02/11/2026 | 17,88% | 82,49% | ** |
